Your browser doesn't support javascript.
loading
Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications.
Li, Jia-Kun; Tang, Tong; Zong, Hui; Wu, Er-Man; Zhao, Jing; Wu, Rong-Rong; Zheng, Xiao-Nan; Zhang, Heng; Li, Yi-Fan; Zhou, Xiang-Hong; Zhang, Chi-Chen; Zhang, Zi-Long; Zhang, Yi-Hang; Feng, Wei-Zhe; Zhou, Yi; Wang, Jiao; Zhu, Qi-Yu; Deng, Qi; Zheng, Jia-Ming; Yang, Lu; Wei, Qiang; Shen, Bai-Rong.
Affiliation
  • Li JK; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Tang T; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zong H; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wu EM; Department of Computer Science and Information Technologies, Elviña Campus, University of A Coruña, 15001, A Coruña, Spain.
  • Zhao J; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wu RR; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zheng XN; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhang H; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Li YF; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhou XH; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhang CC; Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, OX1 2JD, UK.
  • Zhang ZL; Department of Radiology, National Clinical Research Center for Geriatric Diseases/the Second Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
  • Zhang YH; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Feng WZ; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhou Y; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wang J; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhu QY; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Deng Q; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zheng JM; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Yang L; Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Wei Q; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Shen BR; Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Mil Med Res ; 11(1): 58, 2024 Aug 21.
Article in En | MEDLINE | ID: mdl-39164787
ABSTRACT
Robot-assisted surgery has evolved into a crucial treatment for prostate cancer (PCa). However, from its appearance to today, brain-computer interface, virtual reality, and metaverse have revolutionized the field of robot-assisted surgery for PCa, presenting both opportunities and challenges. Especially in the context of contemporary big data and precision medicine, facing the heterogeneity of PCa and the complexity of clinical problems, it still needs to be continuously upgraded and improved. Keeping this in mind, this article summarized the 5 stages of the historical development of robot-assisted surgery for PCa, encompassing the stages of emergence, promotion, development, maturity, and intelligence. Initially, safety concerns were paramount, but subsequent research and engineering advancements have focused on enhancing device efficacy, surgical technology, and achieving precise multi modal treatment. The dominance of da Vinci robot-assisted surgical system has seen this evolution intimately tied to its successive versions. In the future, robot-assisted surgery for PCa will move towards intelligence, promising improved patient outcomes and personalized therapy, alongside formidable challenges. To guide future development, we propose 10 significant prospects spanning clinical, research, engineering, materials, social, and economic domains, envisioning a future era of artificial intelligence in the surgical treatment of PCa.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Robotic Surgical Procedures Limits: Humans / Male Language: En Journal: Mil Med Res Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Robotic Surgical Procedures Limits: Humans / Male Language: En Journal: Mil Med Res Year: 2024 Document type: Article Affiliation country: China